Miguel Tovarflipped into Pharma readings Novartis' migraine drug gets EMA approval pharmatimes.com Aimovig becomes Europe’s first treatment specifically designed to prevent migraine
Miguel Tovarflipped into Pharma readings Pfizer CEO on what happened after Trump tweeted CNBC - Meg Tirrell Before he even spoke to the president, Pfizer CEO Ian Read said he knew the best move was to defer the drug giant's early July price increases; a …
Miguel Tovarflipped into Pharma readings Kyoto team pits iPS cells against Parkinson's disease japantimes.co.jp - No Author A Kyoto University research team said Monday it will begin a clinical test this week using induced pluripotent stem cells to treat Parkinson’s …
Miguel Tovarflipped into Pharma readings Highly Anticipated Data On Would-Be Alzheimer's Drug Raises Hope And Questions Forbes - Ellie KincaidHow does Biogen Chief Medical Officer Al Sandrock feel after the curtain was lifted on clinical trial data of the experimental Alzheimer’s drug his company is developing with Japanese drugmaker Eisai?
Miguel Tovarflipped into Pharma readings GSK bets $300 million on genetics as CEO plays down break-up talk Reuters - Ben HirschlerLONDON (Reuters) - GlaxoSmithKline aims to turbo-charge its drug discovery engine with a big bet on genetics as its CEO on Wednesday played down the idea of hiving off consumer healthcare, which is a of
Miguel Tovarflipped into Pharma readings Eisai, Biogen battered by controversy over PhII Alzheimer's study after posting positive results endpts.com - John Carroll At first blush, Eisai and Biogen posted the kind of promising data for BAN2401 that might have overcome some doubts about its potential as a …
